Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Intervertebral disc (IVD) degeneration is associated with proteolytic degradation of proteoglycan aggregates present within the extracellular matrix of the disc. Link N peptide (DHLSDNYTLDHDRAIH) is the N-terminal peptide of link protein, which stabilizes the proteoglycan aggregates. It is generated in vivo by proteolytic degradation during tissue turnover. It has been previously shown that this peptide can stimulate the synthesis of collagens by articular cartilage and bovine IVD cells in vitro. Being a synthetic peptide, Link N has considerable financial benefits for clinical use over recombinant growth factors because it is extremely cheap to produce. The purpose of the present study was to determine the effect of Link N on the expression of types I and II collagen and investigate the cellular mechanisms of Link N signal transduction in human IVD cells. The present results suggest that Link N stimulates the expression of types I and II collagen in human IVD cells. More specifically, Link N stimulated the expression of type I in nucleus pulposus (NP) cells, but not in annulus fibrosus cells. As Link N also decreased the phosphorylation of p38 in NP cells only, results suggest that p38 is a mediator of the effect of Link N on type I collagen expression. p38 is a member of the mitogen-activated protein kinase family highlighted by three major cascades: p38, c-Jun amino-terminal kinase, and extracellular signal-regulated kinase pathways. Link N showed no effect on the latter two pathways, suggesting a specific effect of Link N on the p38 cascade. On the other hand, Link N stimulated the expression of type II collagen in both NP and annulus fibrosus, suggesting that other mechanisms are implicated in the control of type II collagen expression in disc cells, without excluding p38 for the NP. In conclusion, the present study showed that Link N can modulate the expression of collagen in human IVD cells.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/ten.TEA.2010.0494 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Human Progenitor Cell-Based Tissue Engineered Intervertebral Disc.
Tissue Eng Part A
September 2025
Department of Orthopaedic Surgery, McKay Orthopaedic Research Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Cell and tissue engineering therapies provide promise for regenerating damaged intervertebral disc (IVD) tissue and resolving the low back pain that often accompanies it. However, these treatments remain experimental and unavailable for patients. Furthermore, the large body of work characterizing and utilizing mesenchymal stromal cells (MSCs) for these applications has, unfortunately, not resulted in any FDA-approved spinal therapies.
View Article and Find Full Text PDFHydrogel adhesives with a hydrodynamically induced liquid-solid transition for annular fissure sealing and inflammation modulation following microdiscectomy.
J Orthop Translat
November 2025
Medical 3D Printing Center, Orthopedic Institute, Department of Orthopedic Surgery, The First Affiliated Hospital, School of Basic Medical Sciences, Interdisciplinary Innovation Center for Nanomedicine, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College, Soochow Universi
Background: Intervertebral disc (IVD) herniation is a major cause of low back pain and disability, with microdiscectomy being the standard surgical treatment. However, microdiscectomy fails to address annulus fibrosus (AF) defects, increasing the risk of recurrent herniation. Current therapeutic strategies for this condition remain limited in efficacy.
View Article and Find Full Text PDFLocal RANTES/CCL5 Delivery and Peripheral Blood Mobilization of Endogenous Marrow-Derived Mesenchymal Stem Cells to Mitigate Lumbar Intervertebral Disc Degeneration.
Global Spine J
August 2025
Department of Orthopaedic Surgery, Beaumont Health, Royal Oak, MI, USA.
Study DesignTranslational rodent study.ObjectivesTo investigate (1) chemokine-mediated mesenchymal stem cell mobilization and homing to the intervertebral disc and (2) using this technique to mitigate intervertebral disc degeneration in a rat model.Methods(1) Recruitment of mesenchymal stem cells (MSCs) to intervertebral discs (IVD) was investigated using intradiscal chemokines.
View Article and Find Full Text PDFA pH/ROS dual responsive smart microgel miRNA delivery system for repair of intervertebral disc degeneration.
J Mater Chem B
August 2025
Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
The progression of intervertebral disc degeneration (IDD) is due to the progressive exacerbation of apoptosis and impaired extracellular matrix (ECM) synthesis, both of which are induced by progressive inflammation. Therefore, addressing the inflammatory microenvironment and correcting excessive apoptosis of nucleus pulposus cells (NPCs) are key to achieving intervertebral disc (IVD) regeneration. In this study, we designed a microenvironment-responsive smart microgel gene delivery system that for the first time combines phenylboronic acid-functionalized microgels with strontium sulfite nanoparticles to load miR-155 to enhance their anti-apoptosis capacity and promote ECM regenerative effects.
View Article and Find Full Text PDFExploring the potential anti-apoptotic effects of traditional Chinese medicine in intervertebral disc degeneration: mechanisms and therapeutic prospects.
Front Physiol
August 2025
The Third Affiliated Hospital of Xinxiang Medical University, Clinical Medical Center of Tissue Engineering and Regeneration, Zhongyuan Regenerative Medicine Laboratory, Xinxiang Medical University, Xinxiang, China.
Intervertebral disc degeneration (IDD) stands as one of the primary culprits behind low back pain and disability, imposing substantial burdens on individual health, families, and societal wellbeing. The multifactorial etiology and complex pathology of IDD pose significant challenges, with molecular mechanisms still not fully elucidated. A key aspect of the pathogenesis of IDD involves programmed cell death, specifically apoptosis, which exacerbates the condition by fostering the apoptosis of intervertebral disc (IVD) cells and accelerating the degradation of the extracellular matrix (ECM).
View Article and Find Full Text PDF